Related Experiment Video
Updated: Aug 19, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
DDIT4 promotes malignancy of head and neck squamous cell carcinoma
Zhenxing Zhang1, Haoran Zhu2, Chifeng Zhao1
1Department of Stomatology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang Province, China.
Abstract:
This study investigated the cancer-promoting effect of ferroptosis regulator DNA damage-inducible transcript 4 (DDIT4) and its relevant mechanisms. Vital ferroptosis-related genes were identified using bioinformatic methods on the basis of data collected from TCGA and seven other online databases. Cell Counting Kit-8 (CCK8), colony formation, wound-healing and transwell assays, and western blot analysis were conducted for verifying the biological role of DDIT4 in vitro. The immune score and tumor purity were calculated using R package "estimate." The relationship was identified between DDIT4 expression and immune cell infiltration using ssGSEA and CIBERSORT algorithms. R package "Seurat" was used to perform unsupervised clustering of the single cells, and "SingleR" was utilized for annotation. R package "STUtility" was employed to plot the spatial expression of DDIT4. For trajectory analysis, monocle was used to predict cell differentiation and demonstrate the expression of DDIT4 at each state. Here, DDIT4 overexpression was observed in Head and Neck Squamous Cell Carcinoma (HNSCC) cohort, and DDIT4 upregulation showed a positive correlation with larger tumor size, lymph node metastasis, more advanced TNM stage and higher tumor mutational burden (TMB). Moreover, DDIT4 knockdown could markedly inhibit the proliferation, colony formation, invasion and migration of HNSCC cells, as well as suppress the expression of HIF-1a, VEGF and vimentin. In comparison, DDIT4 overexpression showed a negative correlation with immune score and infiltrations of several immune cells. DDIT4 played crucial roles in the differentiation of CAFs and T cells. Collectively, this study demonstrates that DDIT4 contributes a critical role in HNSCC progression. The positive feedback regulation between DDIT4 and HIF-1a may be a potential target for HNSCC treatment.
Insights
DNA damage-inducible transcript 4 (DDIT4) promotes Head and Neck Squamous Cell Carcinoma (HNSCC) progression by affecting cell proliferation and immune infiltration. Targeting the DDIT4 and HIF-1a feedback loop may offer new HNSCC treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Ferroptosis regulators play critical roles in cancer development.
- DNA damage-inducible transcript 4 (DDIT4) is implicated in various cellular processes.
- Understanding DDIT4's role in Head and Neck Squamous Cell Carcinoma (HNSCC) is crucial for therapeutic advancements.
Purpose of the Study:
- To investigate the cancer-promoting effects of DDIT4 in HNSCC.
- To elucidate the underlying mechanisms of DDIT4's action.
- To explore potential therapeutic targets related to DDIT4 in HNSCC.
Main Methods:
- Bioinformatic analysis of ferroptosis-related genes using TCGA and multiple databases.
- In vitro assays including CCK8, colony formation, wound-healing, and transwell assays.
- Analysis of immune cell infiltration, spatial expression, and cell differentiation using advanced R packages and single-cell sequencing.
Main Results:
- DDIT4 overexpression is linked to advanced stage, metastasis, and higher tumor mutational burden in HNSCC.
- DDIT4 knockdown inhibits HNSCC cell proliferation, invasion, and migration, suppressing HIF-1a, VEGF, and vimentin.
- DDIT4 expression negatively correlates with immune score and infiltration of key immune cells, impacting CAF and T cell differentiation.
Conclusions:
- DDIT4 significantly promotes HNSCC progression.
- The positive feedback loop between DDIT4 and HIF-1a presents a potential therapeutic target for HNSCC.
- DDIT4 influences the tumor microenvironment and immune cell dynamics in HNSCC.
Related Concept Videos
Abnormal Proliferation
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

